Bluejay Diagnostics price to book ratio BJDX
Market value divided by the book value of the company's net assets, since 2022.
- Today, Nov 2, 2026
- 0.1×
- 5-year median
- 0.1×
- Against its 5-year history
- 15th
- percentile: 0 is its lowest day, 100 its highest
- 5-year range
- 0.0× to 0.4×
- Peer median
- 0.3×
Bluejay Diagnostics' price to book ratio is 0.1× as of Nov 2, 2026.
That is below its 5-year median of 0.1×, lower than on 85% of days in the last 5 years.
Over that time it ranged from 0.0× in Aug 2024 to 0.4× in Jul 2022.
The median for 10 medical instruments and supplies stocks of a similar size is 0.3×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 0.1× | 0.1× | 0.3× |
| 2025 | 0.1× | 0.0× | 0.2× |
| 2024 | 0.1× | 0.0× | 0.2× |
| 2023 | 0.1× | 0.1× | 0.3× |
| 2022 | 0.1× | 0.1× | 0.4× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Bluejay Diagnostics' size, closest first, today.
| Company | Price to book ratio |
|---|---|
| BJDXBluejay Diagnostics | 0.1× |
| VJETFlyte Aviation | 0.0× |
| PFSAProfusa | n/m |
| IVFINVO Fertility | 0.1× |
| BBLGBone Biologics | 0.2× |
| TNONTenon Medical | n/m |
| AMIXAutonomix Medical | 0.5× |
| NXGLNexgel | 0.4× |
| ADGMAdagio Medical | n/m |
| GCTKGlucotrack | n/m |
| XAIRBeyond Air | 1.1× |
| Peer median | 0.3× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Bluejay Diagnostics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.